Prefrontal cortex and executive function impairments in primary breast cancer.
about
Cognitive training for improving executive function in chemotherapy-treated breast cancer survivorsThe Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain"Chemotherapy-related cognitive impairment in older patients with cancerCancer- and cancer treatment-associated cognitive change: an update on the state of the sciencePsychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovationsCognitive function and breast cancer: promise and potential insights from functional brain imaging.Opening up the window into "chemobrain": a neuroimaging reviewFunctional MRI studies in non-CNS cancers.Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.Default mode network as a potential biomarker of chemotherapy-related brain injuryChemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.Verbal fluency in breast cancer patients treated with chemotherapy.Prevalence, mechanisms, and management of cancer-related cognitive impairment.Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients.Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.Altered small-world properties of gray matter networks in breast cancerEffects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysisNeurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review.Systemic chemotherapy decreases brain glucose metabolism.Relationships among attention function, exercise, and body mass index: a comparison between young breast cancer survivors and acquaintance controls.Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsCognitive impairment after chemotherapy related to atypical network architecture for executive control.Brain network alterations and vulnerability to simulated neurodegeneration in breast cancerAlterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivorsDoes tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivorsCognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.Comparing connectivity pattern and small-world organization between structural correlation and resting-state networks in healthy adults.YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial: Investigating Relationships Between Memory and SleepDefault mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls.Sex-specific effects of cytotoxic chemotherapy agents cyclophosphamide and mitomycin C on gene expression, oxidative DNA damage, and epigenetic alterations in the prefrontal cortex and hippocampus - an aging connectionElevated prefrontal myo-inositol and choline following breast cancer chemotherapy.Brain vulnerability to chemotherapy toxicities.Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates.Neuroimaging, cancer, and cognition: state of the knowledge.
P2860
Q24594173-311381A6-87BB-4C70-8C7C-D6C5C87A1A45Q26743578-DD5573CC-6194-4C9A-8B83-593D4A9BCAAFQ26747612-BAD195BA-16A8-4E81-B687-D2F44B218D18Q26853289-E81A3DA7-F3C1-4849-9BD4-3E40D2C4836AQ27007708-04838527-3FA7-45AD-A798-25DF8FF257B2Q30572890-AEBF7CD7-B1E8-4E60-81DB-1D0FC1AF2876Q30596880-F88ED6FE-33B3-4882-BCA2-8654B8A3DB51Q30660824-BB364BA5-6F8D-490F-8DA8-3F49264133C1Q30664513-F881211E-AFD7-4215-9C14-B80634ABB3AEQ30830124-7F8FB687-743B-4E91-8420-D8ED900C58C3Q33360883-3DE41A67-5A60-4E8C-A753-E7553B931541Q33575742-85660E27-DB7A-4275-86D0-65C9833847FEQ33854977-D5878ABC-1738-4A58-AFA6-8B241B1101C2Q34031141-F6BEB606-9883-4870-9C9A-C95AB6610C21Q34110937-1E6413E0-C6EB-4A07-8225-1E4DC96FE1BCQ34194470-9B2A767F-D1F7-4EC6-BCF2-1DB629110E68Q34282795-A9052ED5-C25F-4CE5-A380-C05E514D67BCQ34394243-20E7BC73-572D-48D6-97ED-FDB5425D3875Q34503992-541671B4-E2C5-48EB-98D9-A6F287427B9CQ34553351-F542B992-FCEA-4A27-A6DD-D7B5F9D23184Q34562855-F9411801-DFAC-4AE4-8A8B-D7B4E5A28F26Q34725661-5B73A76F-B610-4FE3-A742-31EF673C4B6BQ35164117-E1749159-7614-4866-8DEC-DE93D5B5CB50Q35667533-600D2813-1D53-44B1-9571-32A3D7E9C19EQ35732380-AD391CCD-BEBE-4E91-8D37-513EC6A492EEQ36097701-54EF58CF-5FAB-4E6D-9D36-F506C2D3A3C1Q36287777-842B0F37-0675-4513-A136-350B56222216Q36468050-98B23B76-4A6E-4BC4-B7E3-2A0DA829123FQ36528154-978E7D1A-AC59-46B2-A55B-D57A2DA688F3Q36775693-48F85001-D189-471B-B28A-96A80E53F4DAQ36880990-58269BB6-E569-4B72-B5BF-10A719F91451Q36901307-C7079500-44E7-447D-BD91-7ACB8D65659EQ36905873-5CA5411C-EDED-461B-82B4-36943418367EQ36945894-131C4F43-07C3-43B3-8CD8-2E9C22F87EBBQ37010580-3B56103A-34AB-4B2A-AA00-54D5E9038F15Q37049097-34A503CD-E111-4D07-8A21-5E77E81A1288Q37064264-F87F240B-FE59-468E-98EF-B946913D08CBQ37211338-88C400E8-B9CA-4C15-A63F-1D0673047031Q37284872-DB698E48-612E-4136-8403-8013805F034FQ37292321-A573F87D-E635-45F4-B357-1D576E14A186
P2860
Prefrontal cortex and executive function impairments in primary breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prefrontal cortex and executive function impairments in primary breast cancer.
@ast
Prefrontal cortex and executive function impairments in primary breast cancer.
@en
type
label
Prefrontal cortex and executive function impairments in primary breast cancer.
@ast
Prefrontal cortex and executive function impairments in primary breast cancer.
@en
prefLabel
Prefrontal cortex and executive function impairments in primary breast cancer.
@ast
Prefrontal cortex and executive function impairments in primary breast cancer.
@en
P2093
P2860
P1433
P1476
Prefrontal cortex and executive function impairments in primary breast cancer.
@en
P2093
Jamie S Kent
Ruth O'Hara
Shelli R Kesler
P2860
P304
P356
10.1001/ARCHNEUROL.2011.245
P577
2011-11-01T00:00:00Z